Cosciens Biopharma Inc (CSCI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CSCI Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Cosciens Biopharma Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents7.31
Current Tax Assets Current0.00
Cash & Short-term Investments7.00
Accounts receivable1.08
Inventories1.31
Other Current Assets0.00
Total Current Assets11.50
Equipment/Property/Plant Net9.81
Long-term investments0.13
Tax Assets, Noncurrent1.12
Other Assets, Noncurrent0.69
Total Assets21.43
Liabilities
Current Tax Liabilities0.12
Other Liabilities, Current3.49
Deferred Liability and Revenue0.00
Total Current Liabilities3.61
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent1.12
Noncurrent Provisions12.86
Total Liabilities17.59
Stockholders' Equity
Common Stockholder's Equity3.84
Total Stockholder's Equity3.84
Liabilities & Stockholder's Equity21.43
4 historic quarters locked

Sign in to unlock the full Cosciens Biopharma Inc balance sheet history.

About Cosciens Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012703

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.